Skip to main content

Advertisement

Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia

Article metrics

  • 216 Accesses

The original article was published in Journal of Translational Medicine 2019 17:163

Correction to: J Transl Med (2019) 17:163 https://doi.org/10.1186/s12967-019-1901-8

Following publication of the original article [1], the authors found an error in Fig. 3. The middle panel of Fig. 3a was inadvertently duplicated.

In this Correction the incorrect and corrected version of Fig. 3 are shown.

Originally Fig. 3 was published as:

Fig. 3
figure3

a Treatment with triptolide resulted in a decrease in colony forming ability of AML cell lines THP-1 and KG1a as measured by a methylcellulose based colony forming assay. Treatment with triptolide also caused a decrease in surface markers of commonly expressed stem cell markers in AML cell lines THP-1 (b) and KG1a (c). n = 3, *p < 0.05 when compared to untreated cells, data shows mean ± SD

The corrected version of Fig. 3:

Fig. 3
figure4

a Treatment with triptolide resulted in a decrease in colony forming ability of AML cell lines THP-1 and KG1a as measured by a methylcellulose based colony forming assay. Treatment with triptolide also caused a decrease in surface markers of commonly expressed stem cell markers in AML cell lines THP-1 (b) and KG1a (c). n = 3, *p < 0.05 when compared to untreated cells, data shows mean ± SD

Reference

  1. 1.

    Giri B, Gupta VK, Yaffe B, Modi S, Roy P, Sethi V, Lavania SP, Vickers SM, Dudeja V, Banerjee S, Watts J, Saluja A. Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia. J Transl Med. 2019;17:163. https://doi.org/10.1186/s12967-019-1901-8.

Download references

Author information

Correspondence to Ashok Saluja.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Giri, B., Gupta, V.K., Yaffe, B. et al. Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia. J Transl Med 17, 301 (2019) doi:10.1186/s12967-019-2048-3

Download citation